We are live on ! Find out more
BFG

Bleakley Financial Group Portfolio holdings

AUM $6.39B
1-Year Est. Return 26.33%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
10 Year Est. Return
AUM
$3.2B
AUM Growth
+$209M
Cap. Flow
+$66.4M
Cap. Flow %
2.07%
Top 10 Hldgs %
28.66%
Holding
997
New
87
Increased
510
Reduced
305
Closed
71

Sector Composition

Rank Sector Weight
1 Technology 11.85%
2 Healthcare 10.44%
3 Financials 5.01%
4 Consumer Discretionary 4.57%
5 Communication Services 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
76
Walmart Inc
WMT
$884B
$8.4M 0.26%
160,368
+8,376
+6% +$423K
REGN icon
77
Regeneron Pharmaceuticals
REGN
$77.4B
$8.28M 0.26%
11,517
+188
+2% +$145K
CSCO icon
78
Cisco
CSCO
$448B
$8.21M 0.26%
158,592
+2,947
+2% +$145K
CGXU icon
79
Capital Group International Focus Equity ETF
CGXU
$6.3B
$8.12M 0.25%
345,049
+17,249
+5% +$402K
STIP icon
80
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$8.05M 0.25%
82,496
+205
+0.2% +$20.2K
IWF icon
81
iShares Russell 1000 Growth ETF
IWF
$120B
$7.95M 0.25%
115,508
-8,120
-7% -$516K
MCD icon
82
McDonald's
MCD
$191B
$7.91M 0.25%
26,509
+2,476
+10% +$719K
HCA icon
83
HCA Healthcare
HCA
$85.7B
$7.85M 0.24%
25,852
+21,593
+507% +$6M
BOND icon
84
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.4B
$7.47M 0.23%
81,531
+5,977
+8% +$551K
URTH icon
85
iShares MSCI World ETF
URTH
$7.98B
$7.38M 0.23%
59,247
-410
-0.7% -$49.2K
PM icon
86
Philip Morris
PM
$299B
$7.22M 0.23%
73,975
+6,601
+10% +$631K
VHT icon
87
Vanguard Health Care ETF
VHT
$18.3B
$7.18M 0.22%
29,334
-5,639
-16% -$1.37M
APLS
88
DELISTED
Apellis Pharmaceuticals
APLS
$7.17M 0.22%
78,687
-103,190
-57% -$8.9M
VXUS icon
89
Vanguard Total International Stock ETF
VXUS
$155B
$6.94M 0.22%
123,813
+12,646
+11% +$707K
ASML icon
90
ASML
ASML
$634B
$6.82M 0.21%
9,407
+1,727
+22% +$1.17M
PFF icon
91
iShares Preferred and Income Securities ETF
PFF
$13.3B
$6.46M 0.2%
208,836
-544
-0.3% -$16.6K
IWR icon
92
iShares Russell Mid-Cap ETF
IWR
$56.1B
$6.33M 0.2%
86,628
-513
-0.6% -$35.7K
WMB icon
93
Williams Companies
WMB
$86.7B
$6.32M 0.2%
193,736
+13,939
+8% +$418K
CRM icon
94
Salesforce
CRM
$148B
$6.31M 0.2%
29,852
+7,015
+31% +$1.43M
PFE icon
95
Pfizer
PFE
$142B
$6.26M 0.2%
170,549
+7,607
+5% +$296K
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$122B
$6.24M 0.19%
17,736
+9,704
+121% +$3.27M
IVW icon
97
iShares S&P 500 Growth ETF
IVW
$72.7B
$6.23M 0.19%
88,388
-633
-0.7% -$41.8K
FIS icon
98
Fidelity National Information Services
FIS
$23.8B
$6.15M 0.19%
112,345
+1,251
+1% +$68.8K
DXJ icon
99
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
$5.99M 0.19%
71,909
+417
+0.6% +$31.7K
GDX icon
100
VanEck Gold Miners ETF
GDX
$23.5B
$5.95M 0.19%
197,774
+817
+0.4% +$26.6K

Similar funds

Bleakley Financial Group's Q2 2023 Portfolio in Review

As of Q2 2023, Bleakley Financial Group held 997 positions worth $3.2B, up 7% from $3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bleakley Financial Group's Q2 2023 filing shows 87 new, 510 increased, 305 reduced and 71 closed positions. Its largest new stake was Monro: 54,860 shares worth $2.23M. The largest sale was Apellis Pharmaceuticals, an estimated $8.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Bleakley Financial Group's largest Q2 2023 buy was Monro: 54,860 shares worth $2.23M.
  • Bleakley Financial Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2023, an estimated $6.61M increase.
  • Bleakley Financial Group's biggest Q2 2023 reduction was Apellis Pharmaceuticals, cutting an estimated $8.9M.
  • Bleakley Financial Group fully exited ABB Ltd in Q2 2023, selling an estimated $3.61M.
  • Bleakley Financial Group's ten largest holdings make up 29% of its $3.2B portfolio in Q2 2023.
  • Bleakley Financial Group opened 87 new positions and closed 71 in Q2 2023.
  • Bleakley Financial Group's portfolio value rose 7% quarter-over-quarter to $3.2B.

Based on Bleakley Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.